Related Experiment Video
Updated: Dec 23, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer
Xiaolong Shi1, Markus Kaller1, Matjaz Rokavec1
1Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.
Background & Aims:
The miR-34a gene is a direct target of p53 and is commonly silenced in colorectal cancer (CRC). Here we identified the receptor tyrosine kinase CSF1R as a direct miR-34a target and characterized CSF1R as an effector of p53/miR-34a-mediated CRC suppression.
Methods:
Analyses of TCGA-COAD and three other CRC cohorts for association of mRNA expression and signatures with patient survival and molecular subtypes. Bioinformatics identification and experimental validation of miRNA and transcription factor targets. Functional analysis of factors/pathways in the regulation of epithelial-mesenchymal transition (EMT), invasion, migration, acquired chemo-resistance and metastasis. Analyses of protein expression and CpG methylation within primary human colon cancer samples.
Results:
In primary CRCs increased CSF1R, CSF1 and IL34 expression was associated with poor patient survival and a mesenchymal-like subtype. CSF1R displayed an inverse correlation with miR-34a expression. This was explained by direct inhibition of CSF1R by miR-34a. Furthermore, p53 repressed CSF1R via inducing miR-34a, whereas SNAIL induced CSF1R both directly and indirectly via repressing miR-34a in a coherent feed-forward loop. Activation of CSF1R induced EMT, migration, invasion and metastasis of CRC cells via STAT3-mediated down-regulation of miR-34a. 5-FU resistance of CRC cells was mediated by CpG-methylation of miR-34a and the resulting elevated expression of CSF1R. In primary CRCs elevated expression of CSF1R was detected at the tumor invasion front and was associated with CpG methylation of the miR-34a promoter as well as distant metastasis.
Conclusions:
The reciprocal inhibition between miR-34a and CSF1R and its loss in tumor cells may be relevant for therapeutic and prognostic approaches towards CRC management.
Insights
The study reveals that CSF1R is a direct target of miR-34a, and their interaction impacts colorectal cancer (CRC) progression. Loss of this miR-34a/CSF1R axis promotes CRC metastasis and chemoresistance.
Area of Science:
- Molecular oncology
- Cancer epigenetics
- Tumor microenvironment
Background:
- The tumor suppressor p53 regulates miR-34a, which is frequently silenced in colorectal cancer (CRC).
- Receptor tyrosine kinase CSF1R is identified as a direct target of miR-34a.
- CSF1R acts as an effector in p53/miR-34a-mediated CRC suppression.
Purpose of the Study:
- To investigate the role of CSF1R as a direct target of miR-34a in colorectal cancer.
- To elucidate the functional consequences of the p53/miR-34a/CSF1R axis in CRC progression, metastasis, and chemoresistance.
- To explore the therapeutic and prognostic implications of the miR-34a-CSF1R interaction in CRC management.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) and other CRC cohorts for gene expression and patient survival.
- Bioinformatic identification and experimental validation of microRNA and transcription factor targets.
- Functional assays assessing epithelial-mesenchymal transition (EMT), invasion, migration, chemoresistance, and metastasis.
- Analysis of protein expression and CpG methylation in human colon cancer samples.
Main Results:
- Increased CSF1R, CSF1, and IL34 expression correlated with poor survival and mesenchymal subtype in primary CRCs.
- CSF1R expression inversely correlated with miR-34a, due to direct miR-34a inhibition of CSF1R.
- p53 induced miR-34a to repress CSF1R; SNAIL repressed miR-34a to induce CSF1R.
- CSF1R activation promoted CRC cell EMT, migration, invasion, and metastasis via STAT3.
- CpG methylation of miR-34a and subsequent CSF1R elevation mediated 5-FU resistance.
- Elevated CSF1R at the tumor invasion front associated with miR-34a promoter methylation and distant metastasis.
Conclusions:
- The reciprocal inhibition between miR-34a and CSF1R, and its disruption in tumors, holds potential for CRC therapeutic and prognostic strategies.
- Targeting the miR-34a-CSF1R axis could offer novel approaches for colorectal cancer treatment.
- Understanding the epigenetic regulation of miR-34a is crucial for managing CRC progression and chemoresistance.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

